Pfizer Inc
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
LIFW MSP Recovery Inc
ASNS Actelis Networks Inc
AHI Advanced Health Intelligence Ltd
OTLK Outlook Therapeutics Inc
PBHC Pathfinder Bancorp Inc (MARYLAND)
CMA Comerica Inc
IART Integra Lifesciences Holdings Corp
ARKW.SO ARK Next Generation Internet ETF
AGNC Agnc Investment Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operates through two segments: Biopharma and PC1. Biopharma is engaged in the science-based biopharmaceutical business. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. The Company’s primary care products include Eliquis, Nurtec ODT/Vydura and the Premarin family; the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac and Trumenba; Comirnaty, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Eucrisa/Staquis and Cibinqo; the Vyndaqel family, Oxbryta, BeneFIX and Genotropin, and Sulperazon, Medrol, Zavicefta, Zithromax, Vfend and Panzyga. Its oncology products include Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena and Braftovi.

Postmarket

Last Trade
Delayed
$33.31
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$33.31
Day's Change
-0.59 (-1.74%)
Bid
--
Ask
--
B/A Size
--
Day's High
34.08
Day's Low
33.01
Volume
(Light)
Volume:
23,720,839

10-day average volume:
29,694,171
23,720,839

PFE's position in the Pharmaceuticals industry

Industry PeersPFEABBVMRKAMGNBMY

Summary

Company ProfilePfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the...
AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and...
Go to ABBV summary
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, including biological therapies, vaccines and animal health products. The...
Go to MRK summary
Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company’s marketed...
Go to AMGN summary
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical...
Go to BMY summary
52-Week Change

VS. INDUSTRY
-23.20%
6.59%
16.24%
13.27%
-18.87%
Market Cap

VS. INDUSTRY
$191.4B
$260.2B
$258.2B
$139.6B
$119.5B
Beta

VS. INDUSTRY
0.6
0.5
0.4
0.6
0.4
Dividend Yield

VS. INDUSTRY
4.84%
4.02%
2.87%
3.26%
3.98%
P/E (TTM, GAAP)

VS. INDUSTRY
9.03x
30.33x
83.51x
17.59x
15.23x
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$77.9B
$56.0B
$58.3B
$26.6B
$45.2B
Profit Margin

VS. INDUSTRY
27.64%
15.52%
5.36%
30.02%
17.65%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
22.73%
13.33%
25.61%
1.96%
4.53%
Revenue Growth (TTM)

VS. INDUSTRY
-22.88%
-2.31%
2.00%
0.75%
-4.15%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.